Trials / Sponsors / Dynogen Pharmaceuticals
Dynogen Pharmaceuticals
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females Irritable Bowel Syndrome | Phase 2 / Phase 3 | 2007-10-01 |
| Terminated | 12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting Vomiting | Phase 2 | 2005-11-01 |
| Completed | 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS Irritable Bowel Syndrome | Phase 2 | 2005-09-01 |
| Completed | A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c Irritable Bowel Syndrome With Constipation, Irritable Bowel Syndrome | Phase 2 | 2005-09-01 |